A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome.

Grants and Contracts Details

StatusActive
Effective start/end date4/6/223/8/23

Funding

  • Crinetics Pharmaceuticals: $2.00